George Lundberg, MD Editor in Chief at Cancer Commons
-
June 13, 2022
Latest Evidence on Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer: A 2022 Update Bookmark
George Lundberg, MD
This scientific research paper from Critical Reviews in Oncology/Hematology discusses current options for treatments known as immune checkpoint inhibitors for people with advanced colorectal cancer..
-
June 10, 2022
Emerging Treatment Options for Advanced or Recurrent Endometrial Cancer Bookmark
George Lundberg, MDThis 2022 scientific review article from the Journal of the Advanced Practitioner in Oncology discusses new treatment options for people with advanced endometrial cancer.
.
-
June 10, 2022
NCI Overview of Uterine Cancer Bookmark
George Lundberg, MDThe National Cancer Institute provides this online overview of uterine cancer that is up-to date, comprehensive, and written specifically for patients.
.
-
June 10, 2022
NCCN Guidelines for Patients: Endometrial Cancer Bookmark
George Lundberg, MDEndometrial cancer is the most common kind of uterine cancer. The nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their most recent guideline for people with endometrial cancer.
.
-
April 20, 2022
Triplet Combination Improves Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer Bookmark
George Lundberg, MDMetastatic carcinoma of the prostate is fatal, but a 3-drug combination treatment can prolong life substantially, according to new clinical trial results outlined by The ASCO Post.
.
-
March 22, 2022
Immunotherapy Approvals Signal a Need for Molecular Testing in Endometrial Cancer Bookmark
George Lundberg, MDMolecular testing often guides choices of immunotherapy, as illustrated in this OncLive story about endometrial cancer.
.
-
March 22, 2022
Immunotherapy to Treat Cancer Bookmark
George Lundberg, MDImmunotherapy uses biological substances, such as your own immune system, to attack cancer cells. Learn more about immunotherapy from the National Cancer Institute.
.
-
March 22, 2022
Biomarker Testing for Cancer Treatment Bookmark
George Lundberg, MDEach person with cancer has unique biomarkers that may determine how well specific treatments might work for them. Learn more from this website all about biomarkers, prepared by the National Cancer Institute.
.
-
March 22, 2022
Targeted Therapy to Treat Cancer Bookmark
George Lundberg, MD“Targeted therapy is a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. It is the foundation of precision medicine.” —Prepared by the National Cancer Institute, this website provides an excellent overview of targeted therapy for treating cancer.
.
-
March 8, 2022
Using Protein Analysis to Understand Esophageal Cancer Bookmark
George Lundberg, MDIn order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.
.
.